Inhibitors | Comment | Organism | Structure |
---|---|---|---|
amprenavir | - |
Human immunodeficiency virus 2 | |
darunavir | - |
Human immunodeficiency virus 2 | |
additional information | analysis of the differences of binding patterns between the two type HIV proteases, HIV-1 protease and HIV-2 protease, and the two inhibitors darunavir and amprenavir using the interaction entropy (IE) method for the entropy change calculation combined with the polarized force field. The functional role of protonation states in the two HIV-2 complexes is investigated revealing that the protonated OD1 atom of Asp25' in B chain is the optimal choice. The bridging water W301 is unfavorable to the binding of HIV-2 complexes, in contrast to HIV-1 protease complexes. The volume of pocket, B-factor of Calpha atoms and the distance of flap tip in HIV-2 complexes are smaller than that of HIV-1 consistently. Predicated hot-spot residues (Ala28/Ala28', Ile50/Ile50', and Ile84/Ile84') are nearly same in the four systems. The contribution to the free energy of Asp30 residue is more favorable in HIV-1 system than in HIV-2 system. Molecular dynamics simulation and binding free energy calculations, and protonation states of the enzymes, overview | Human immunodeficiency virus 2 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 2 | P04584 | Gag-Pol polyprotein; HIV-2 | - |
Synonyms | Comment | Organism |
---|---|---|
HIV-2 protease | - |
Human immunodeficiency virus 2 |
PR2 | - |
Human immunodeficiency virus 2 |